Outcome of Patients Treated With IABP

Recruiting

• Conditions: Acute Coronary Syndrome; Cardiogenic Shock; Left Ventricular Dysfunction; Low Cardiac Output Syndrome; Coronary Artery Disease; Heart Failure; Post-cardiac Surgery

• Registration Number: NCT04405856
• Lead Sponsor: Nanjing Medical University

Brief Summary

Intra-Aortic Balloon Pumps (IABP) is a widely used and effective left ventricular adjuvant therapy. IABP is an inflatable device placed in the aorta that inflates with diastole and deflates with systole. The aim of this study is to investigate the outcome of patients treated With IABP, and to evaluate the short-term and long-term outcomes of patients with IABP.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02-01
• Status Verified: 2020-05
• Study First Submitted: 2020-05-26
• Study First Submitted QC: 2020-05-26
• Last Update Submitted: 2020-05-26
• Study First Posted: 2020-05-28
• Last Update Posted: 2020-05-28
• Primary Completion: 2025-12-31
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Patients receiving IABP for circulatory support

Exclusion Criteria

• Refusal of consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All-cause mortality	30 days after IABP implantation

Secondary Outcome Measures

Name	Time	Method
All-cause mortality	3 months after IABP implantation

Trial Locations

Locations (1)

The first affiliated hospital of nanjing medical university; 🇨🇳 Nanjing, Jiangsu, China